SCHEMBL1007480

SCHEMBL1007480

O=CNc1ncon1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19875447 0.69
SCHEMBL12181713 0.69
SCHEMBL1007478 0.68
SCHEMBL20909 0.65
SCHEMBL29452940 0.65
SCHEMBL1007890 0.64
SCHEMBL1007994 0.64
SCHEMBL28884749 0.63 ALDH1A1 (0.35)
SCHEMBL4087492 0.63 ALDH1A1 (0.35)
SCHEMBL28047875 0.62 ALDH1A1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107295799-A Parg inhibiting compounds 癌症研究科技有限公司 2017-10-24 CN claimed
CN-107295799-A Parg inhibiting compounds 癌症研究科技有限公司 2017-10-24 CN disclosed
US-20110118236-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-05-19 US disclosed
EP-2269990-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2011-01-05 EP disclosed